NCT00375843 Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication Status COMPLETED Phase PHASE4
NCT00375297 Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women Status COMPLETED Phase PHASE4
NCT00373698 Re-Engineering Systems for the Primary Care Treatment for PTSD Status COMPLETED Phase PHASE3
NCT00373022 Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer Status COMPLETED Phase NA
NCT00369343 Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women Status COMPLETED Phase PHASE3
NCT00368940 Problem Adaptation Therapy (PATH) vs. Supportive Therapy in Treating Depressed, Cognitively Impaired Older Adults Status COMPLETED Phase NA
NCT00368862 Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. Status COMPLETED Phase PHASE4
NCT00366652 Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects Status COMPLETED Phase PHASE3
NCT00365690 Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV Status COMPLETED Phase PHASE2/PHASE3
NCT00360451 Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents Status COMPLETED Phase PHASE3
NCT00360399 Identifying Factors That Predict Antidepressant Treatment Response Status COMPLETED Phase NA
NCT00356304 Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression Status COMPLETED Phase PHASE1
NCT00356096 Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances Status COMPLETED Phase PHASE4
NCT00353223 Interpersonal Psychotherapy for Depression in People With Heart Failure Status COMPLETED Phase PHASE1/PHASE2
NCT00352885 Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment Status COMPLETED Phase PHASE4